Company Search:
Advanced Search
Sponsored Links
Diurnal Group PLC Company Snapshot
Diurnal Group PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Diurnal Group PLC with three other pharmaceutical manufacturers in Europe: Medincell SA of France (2019 sales of 1.44 million Euro [US$1.59 million] of which 100% was the conduct of research and development ), Oasmia Pharmaceutical AB of Sweden (1.98 million Swedish Kronor [US$204,138.00 ] of which 65% was Sales of goods), and Oncimmune Holdings PLC (£171,000.00 [US$218,950.11 ] of which 100% was Distribution of testing products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Diurnal Group PLC
  Stock Performance Chart for Diurnal Group PLC
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 31.50p
(Figures in Pounds Sterling)
1 Week -11.3%   13 Weeks 14.5%  
4 Weeks -21.3%   52 Weeks 7.8%  
Diurnal Group PLC Key Data:
  Ticker: DNL Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 1,044,000
(Year Ending Jan 2020).
Employees: 31
  Currency: Pounds Sterling Market Cap: 26,661,285
  Fiscal Yr Ends: June Shares Outstanding: 84,639,001
  Share Type: Ordinary Closely Held Shares: 9,407,316
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.